home / stock / crtpf / crtpf quote
Last: | $2.30 |
---|---|
Change Percent: | 5.5% |
Open: | $2.375 |
Close: | $2.30 |
High: | $2.375 |
Low: | $2.25 |
Volume: | 65,025 |
Last Trade Date Time: | 08/09/2021 04:40:37 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.3 | $2.375 | $2.3 | $2.375 | $2.25 | 65,025 | 08-09-2021 |
$2.18 | $2.02 | $2.18 | $2.185 | $2.02 | 5,928 | 08-06-2021 |
$2.13 | $2.04 | $2.13 | $2.16 | $2.04 | 16,039 | 08-05-2021 |
$2.15 | $2.34 | $2.15 | $2.34 | $2.15 | 10,928 | 08-04-2021 |
$2.2 | $2.25 | $2.2 | $2.265 | $2.2 | 16,623 | 08-03-2021 |
$2.2505 | $2.49 | $2.2505 | $2.49 | $2.05 | 7,154 | 08-02-2021 |
$2.25 | $2.192 | $2.25 | $2.25 | $2.192 | 15,054 | 07-30-2021 |
$2.1122 | $2.02 | $2.1122 | $2.18 | $2.02 | 21,594 | 07-29-2021 |
$2.07 | $2.08 | $2.07 | $2.12 | $2.045 | 25,694 | 07-28-2021 |
$2.081 | $2.1613 | $2.081 | $2.1613 | $2.05 | 11,476 | 07-27-2021 |
$2.175 | $2.15 | $2.175 | $2.2 | $2.1302 | 15,511 | 07-26-2021 |
$2.175 | $2.2 | $2.175 | $2.2 | $2.1221 | 9,495 | 07-23-2021 |
$2.19 | $2.39 | $2.19 | $2.39 | $2.163 | 9,749 | 07-22-2021 |
$2.23 | $2.03 | $2.23 | $2.252 | $2.03 | 31,795 | 07-21-2021 |
$2.11 | $1.92 | $2.11 | $2.12 | $1.92 | 20,354 | 07-20-2021 |
$2.03 | $1.975 | $2.03 | $2.1027 | $1.975 | 41,379 | 07-19-2021 |
$2.1241 | $2.22 | $2.1241 | $2.22 | $2.11 | 24,856 | 07-16-2021 |
$2.22 | $2.36 | $2.22 | $2.36 | $2.18 | 29,936 | 07-15-2021 |
$2.36 | $2.5 | $2.36 | $2.5011 | $2.3567 | 15,443 | 07-14-2021 |
$2.5 | $2.44 | $2.5 | $2.545 | $2.44 | 21,289 | 07-13-2021 |
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Company Name:
CRTPF Stock Symbol:
OTCMKTS Market:
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announced to...
Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardio...
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardi...